PulseAugur
EN
LIVE 06:57:20
中文(ZH) 昂利康：子公司获得异氟烷药品注册证书

Angelikang subsidiary secures drug registration for anesthetic

By PulseAugur Editorial · [1 sources] ·

Angelikang's subsidiary, Fujian Haixi United Pharmaceutical Co., Ltd., has received a Drug Registration Certificate for Isoflurane from China's National Medical Products Administration. Isoflurane is an anesthetic used for the induction and maintenance of general anesthesia. This marks a significant regulatory approval for the company's pharmaceutical arm. AI

RANK_REASON Regulatory approval for a pharmaceutical product. [lever_c_demoted from research: ic=1 ai=0.1]

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Angelikang subsidiary secures drug registration for anesthetic

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Tool
Regulatory approval for a pharmaceutical product. [lever_c_demoted from research: ic=1 ai=0.1]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
product, policy
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Low
Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
Story freshness
120 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Anlikang: Subsidiary Obtains Isoflurane Drug Registration Certificate

    36氪获悉，昂利康公告，近日，公司子公司福建海西联合药业有限公司收到国家药监局签发的异氟烷《药品注册证书》。异氟烷可用于全身麻醉的诱导和维持。

RELATED ENTITIES

RELATED TOPICS